Summary & Overview
HCPCS S2202: Echosclerotherapy
HCPCS Level II code S2202 represents echosclerotherapy, an ultrasound-guided sclerotherapy procedure used to treat varicose veins and venous insufficiency. As an image-guided vascular intervention, this service is performed to collapse and obliterate incompetent superficial veins and reduce symptoms and complications associated with venous reflux. Nationally, echosclerotherapy is relevant for ambulatory vascular care, interventional phlebology, and outpatient procedural billing.
Key payers addressed in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise summary of clinical context and typical service settings, followed by benchmarks and policy considerations where available. The publication covers reimbursement benchmarks, coverage patterns across major payers, coding considerations specific to HCPCS Level II code S2202, and operational implications for outpatient clinics and ambulatory surgical centers.
This summary provides clinicians, billing professionals, and policy analysts with the clinical definition of the service, payer landscape, and a roadmap of what to expect in the full publication: coverage summaries, payer-specific policy excerpts when available, and practical coding notes. Data not available in the input will be noted as such in detailed sections.
Billing Code Overview
HCPCS Level II code S2202 denotes Echosclerotherapy. This service involves ultrasound-guided injection sclerotherapy used to treat venous insufficiency or varicose veins by delivering a sclerosant into targeted veins under imaging guidance.
-
Service type: Image-guided sclerotherapy procedure
-
Typical site of service: Outpatient vascular center, ambulatory surgical center, or physician office with ultrasound capability
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to a vascular clinic with symptomatic varicose veins or recurrent venous insufficiency confirmed by duplex ultrasound. The patient reports leg pain, swelling, visible bulging veins, or recurrent superficial thrombophlebitis despite conservative therapy (compression, elevation). After history, physical exam, and venous duplex demonstrating reflux in targeted saphenous or perforator veins, the vascular specialist schedules an ultrasound-guided sclerotherapy session (echosclerotherapy). The procedure is performed in an outpatient procedure room or ambulatory surgery center under local anesthesia with real-time ultrasound to visualize needle placement and foam or liquid sclerosant delivery. Typical workflow: pre-procedure consent and site marking, ultrasound mapping, sterile prep, local anesthetic, ultrasound-guided injection of sclerosant into the refluxing segment, immediate compression dressing or bandaging, post-procedure duplex or ultrasound confirmation as needed, and discharge with activity and compression instructions and a follow-up visit for clinical and ultrasound reassessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for the procedure due to complexity. |
26 |